Gene Query: SLC35F5

Dataset Description Geneva Score
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 50.25
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 35.67
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 33.91
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 33.47
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 31.92
HNRNPL and its RNA Targets in Prostate Cancer 31.92
Silencing SPIB in attached and floating state of H1703 lung cancer cells 29.42
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 27.8
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 27.8
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 27.11
RNA-seq of young and quiescent MRC-5 human fibroblasts 26.11
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 20.83
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 20.76
SUV420H2 knockdown in PANC-1 20.69
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 19.93
A role for ZNF598 in post-transcriptional gene regulation 19.67
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 19.31
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 19.31
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 18.97
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 18.95
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 18.63
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 17.85
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 17.73
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 17.73
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 17.62
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 17.47
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 17.46
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 17.24
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 17.24
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 17.01
RNAseq analysis of ESRP regulated splicing events in prostate cancer 16.95
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 16.78
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 16.73
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 16.25
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 16.03
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 16.03
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 15.86
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 15.59
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 15.55
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 15.52
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 15.52
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 15.35
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 15.3
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 15.14
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 13.88
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 13.87
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 13.7
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 13.7
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 13.67
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 12.95
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 12.92
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 12.54
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 12.49
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.46
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 12.33
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 12.25
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 12.18
RNA sequencing analysis of selumetinib-resistant CRC cells lines 11.89
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 11.88
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.63
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.25
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 11.21
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 11.07
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.88
LNCaP treated with iBET 10.74
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 10.58
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.56
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 10.56
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 10.5
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 10.5
Toxoplasma gondii infection of human retinal pigment epithelial cells 10.49
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 10.49
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 10.48
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.47
High-Throughput Kinetic Analysis of Fractional Killing 10.47
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.45
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.4
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.39
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 10.32
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 10.32
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 10.3
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 10.21
RNA Seq of HMVEC under hypoxia 10.21
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 10.06
Crizotinib v. DMSO in SW480 cells 10.03
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 10.0
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 9.97
RNA expression following TMPRSS11B overexpression or depletion 9.87
ARID1A and ARID1B loss in HCT116 and TOV21G cells 9.54
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.54
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.5
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 9.36
R430: A potent inbibitor of DNA and RNA viruses 9.36
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.32
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.25
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.25
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 9.24
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 9.2
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 9.17
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 9.17
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 9.17
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 9.12
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 9.12
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 9.09
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 9.09
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.05
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.05
Mitochondrial dsRNA triggers antiviral signalling in humans 9.04
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 9.0
Human cell line and subcutaneous tumor 8.8
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.73
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.66
A sister of NANOG regulates genes expressed in pre-implantation human development 8.59
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.52
Postnatal lipids drive hepatocyte maturation 8.52
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 8.52
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 8.52
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 8.51
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 8.5
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.48
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.46
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.39
High-throughput sequencing of PROMPT-enriched samples. 8.36
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 8.32
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.23
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.1
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 8.07
Differential analysis of gene regulation at transcript resolution by RNA-Seq 8.07
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 8.05
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 8.02
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 8.01
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.97
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.82
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.82
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 7.82
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 7.82
Uridylation by TUT4 and TUT7 marks mRNA for degradation 7.75
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.71
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.71
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.59
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 7.55
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 7.55
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 7.53
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 7.51
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 7.46
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.27
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 7.19
RNA-Seq from early time points in the kidney differentiation protocol 7.11
Mapping interactions for the TNIP2 hub protein 7.1
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 7.09
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.07
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.07
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 7.06
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 7.05
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.05
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.04
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 6.94
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 6.93
The regulartory role of ZCCHC24 in splicing machinery 6.89
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 6.89
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.85
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.81
Reassessment of Exosome Composition 6.76
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.69
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.69
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.66
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.66
RNA-seq of shEZH2 cells 6.62
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 6.61
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.61
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 6.59
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.56
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.56
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 6.54
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.46
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 6.45
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 6.43
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.43
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 6.42
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 6.42
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.4
Differential gene expression of human melanoma cells [RNA-seq] 6.4
Dtx3L and Androgen Signaling in Prostate Cancer 6.4
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 6.39
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 6.39
AR-independent prostate cancer is sustained through FGF signaling 6.39
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.39
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.39
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.35
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.33
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.32
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.31
Transcriptomic profile of human embryonic renal corpuscles 6.27
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 6.25
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.25
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 6.23
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 6.23
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.22
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.1
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 6.09
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 6.04
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.03
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.03
circRNA-sequencing 6.03
Identification of long noncoding RNAs regulated by p53 6.02
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 5.98
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 5.98
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.97
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.96
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 5.95
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 5.95
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 5.95
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 5.95
RNA-sequencing 5.93
Aneuploidy triggers an immune response 5.89
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.87
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.86
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 5.83
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.82
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 5.81
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.77
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 5.77
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.76
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.74
RNA-seq analysis upon ARID1B overexpression 5.71
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.7
Electronic cigarettes 5.7
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 5.67
Transcriptome analysis of BAP1 knockout and restoration 5.67
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 5.65
Systematic discovery of endogenous human ribonucleoprotein complexes 5.63
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 5.62
Modeling Human Cancer-induced Cachexia (Human) 5.6
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 5.6
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 5.6
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 5.6
STX4 Over-Expression in Human islets 5.59
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 5.53
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 5.5
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 5.5
Cerebellar differentiation in Ataxia-Telangiectasia 5.47
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 5.47
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 5.42
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 5.42
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 5.39
RNAseq Study in CC-671 Treated Cal-51 Cells 5.37
Epigenetic reprogramming of melanoma cells by vitamin C treatment 5.36
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.36
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.36
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.35
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.34
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 5.28
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 5.26
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.22
4sU-seq of HFF exposed to salt and heat stress 5.19
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.14
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 5.13
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.12
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.1
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 5.06
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 5.06
RNA-seq differential expression studies: more sequence, or more replication? 5.04
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 5.04
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 5.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.02
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 5.0
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 4.94
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.87
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.87
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.83
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.79
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.79
Interaction between mitoNEET and NAF-1 in cancer cells 4.78
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 4.77
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.76
Transciptomic profiling of human fetal lung samples 4.75
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.71
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.71
The transcriptome effect of overexpressing EZH2 in MCF7 4.67
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.67
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.64
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.64
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.58
PGE2 mediated gene expression changes in human cervical stromal cells 4.57
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.57
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 4.57
Gene expression profiling of leukemia cells following asparagine depletion 4.56
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.53
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.53
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.53
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.51
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.49
Genome-wide discovery of human splicing branchpoints 4.45
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.45
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.44
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.43
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.34
RNAseq of cell lines with knocked in ESR1 mutations 4.34
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.34
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.33
Modeling Familial Cancer with iPSC Approaches 4.32
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.28
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.28
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.18
Loss of CREBBP results in gene expression repression in lymphoma cells 4.18
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.18
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.14
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.09
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.05
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 3.99
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 3.97
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 3.93
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.92
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 3.92
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 3.92
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 3.9
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.89
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 3.89
Identification of a LIF-responsive replication-competent human β cell 3.87
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.86
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.84
6mer seed toxicity in tumour suppressive microRNAs 3.83
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.83
Transcriptional landscape changes during human embryonic stem cell derivation 3.83
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.79
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.77
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.75
Identifying the molecular mode of action of itraconazole in colorectal cancer 3.75
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.72
Regulation of poly(A) tail and translation during the somatic cell cycle 3.71
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.71
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.66
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.61
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 3.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.56
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 3.55
Androgen Receptor-regulated genes in prostate cancer cells 3.54
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.54
Expression data from miR340 overexpressing human A549 cells 3.51
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.45
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.45
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.45
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.43
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.43
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.42
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.41
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.38
mRNA-Seq profiling of human developing kidney 3.37
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.36
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.35
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.28
SF3B1 Degron knockdown RNA-seq 3.25
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.24
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.23
Regulation of protein translation during mitosis 3.2
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.18
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.15
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 3.11
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.09
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.07
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.05
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 3.04
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 3.04
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.03
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.0
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 2.98
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.92
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.89
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.87
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.83
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.83
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.75
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  2.68
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 2.66
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.64
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 2.64
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.58
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.58
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 2.52
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.44
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.44
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 2.42
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.36
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.36
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.31
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.28
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.28
Splicing and epigenetic factors jointly regulate epidermal differentiation 2.25
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.25
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.25
RNA-Seq of PRMT1 overexpression ECA109 cells 2.25
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.21
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.13
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.12
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.06
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 2.01
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.95
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.95
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.95
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.95
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.94
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.93
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.85
Identification of differentially expressed genes between senescence and senescence bypass cells 1.83
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.76
The circadian transcriptional landscape in primary human mammary epithelial cells 1.75
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.74
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.74
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.72
Gene expression changes due to PARP knockdown in human cells 1.72
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.7
Effects of transcription on genome - nuclear lamina interactions 1.7
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.65
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.64
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.6
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.6
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.6
FOXP2's impact on the primate transcriptome 1.59
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.57
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.55
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.53
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.4
Dilated cardiomyopathy vs Myocarditis 1.34
Identification of global XBP1s target gene expression in human prostate cancer cells 1.33
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.31
IMP3 regulated gene expression in breast cancer cells 1.3
MHC Transcriptomic landscape at haplotype-specific resolution 1.25
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.25
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.22
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.22
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 1.19
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.18
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.18
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.13
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.12
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.12
Oncogenic roles of ARID5B in T-ALL 1.1
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.1
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.1
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.09
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.09
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.06
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.99
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 0.98
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.97
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.93
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.9
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.89
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.86
CD73 knockdown effect in pancreatic cancer cell lines 0.84
Transcriptome-wide modulation of splicing by the exon junction complex 0.81
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.78
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.67
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.65
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.65
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.65
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.64
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.64
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.61
Measure transcript integrity using RNA-seq data 0.55
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.54
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.5
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.5
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.5
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.4
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.38
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.38
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.35
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.35
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.35
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.3
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.28
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.25
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.25
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.25
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.24
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.22
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.22
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.2
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.2
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 0.19
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.17
Energy Metabolism during Anchorage-Independence 0.16
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.16
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.16
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.13
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.13
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.12
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.12
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.1
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 0.09
Preclinical model of obesity and ER-positive breast cancer 0.06
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.04
CDK4/6 inhibitor resistance in prostate cancer 0.03
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
A code of mono-phosphorylation modulates the function of RB. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation